Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced as much as 22.5% weight ...

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: There’s not much research on B12 shots for weight loss ...